Evidence map›Paper›PMID 42752806›Full record

ArticleWorld journal of pediatrics : WJP2026

Safety of sirolimus in pediatric vascular anomalies: a BKMR-PopPK exposure-response framework for individualized risk and dosing.

Bo Liu, Xiao-Lin Xu, Jia-Lu Wang, Jia Li, Yu-Xin Wu, Xue-Xi Zhang, Qiao-Yin Liu, Yi-Ming Zhao, Peng Guo, Rui-Qi Zhang and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of pediatrics : WJP, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Bo LiuDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.ORCID http://orcid.org/0009-0007-8614-0942
Xiao-Lin XuDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.ORCID http://orcid.org/0009-0009-0442-1412
Jia-Lu WangDepartment of Otorhinolaryngology-Head and Neck Surgery, Beijing Children's Hospital, No. 56, Nanlishi Road, West District, Beijing, China.
Jia LiDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.
Yu-Xin WuSchool of Artificial Intelligence, University of Chinese Academy of Sciences, 19A Yuquan Road, Shijingshan District, Beijing, China.
Xue-Xi ZhangDepartment of Otorhinolaryngology-Head and Neck Surgery, Beijing Children's Hospital, No. 56, Nanlishi Road, West District, Beijing, China.
Qiao-Yin LiuDepartment of Otorhinolaryngology-Head and Neck Surgery, Beijing Children's Hospital, No. 56, Nanlishi Road, West District, Beijing, China.
Yi-Ming ZhaoDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.
Peng GuoDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.
Rui-Qi ZhangSchool of Computer Science, The University of Sheffield, Regent Court, 211 Portobello, Sheffield, UK.
Han ZhouDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.
Xue-Ting MaoDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.
Yu-Meng JiaDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China.
Xiao-Ling ChengDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China. chengxiaoling1224@163.com.ORCID http://orcid.org/0000-0002-0048-2658
Sheng-Cai WangDepartment of Otorhinolaryngology-Head and Neck Surgery, Beijing Children's Hospital, No. 56, Nanlishi Road, West District, Beijing, China. wsc820329@163.com.ORCID http://orcid.org/0000-0002-8628-5216
Xiao-Ling WangDepartment of Pharmacy, Beijing Children's Hospital, Capital Medical University, No. 56, Nanlishi Road, West District, Beijing, China. wangxiaoling@bch.com.cn.ORCID http://orcid.org/0000-0003-2136-7410

Funding

the Beijing Municipal Administration of Hospitals Incubating Program PX2023043the Capital's Funds for Health Improvement and Research 2022-2Z-2099the Capital's Funds for Health Improvement and Research 2024-2-2097the National Key R&D Program of China 2023YFC2706100the National Natural Science Foundation of China 82271184the Young Scientists Fund of the National Natural Science Foundation of China 82404757
6 · The paper itself

Abstract

backgroundVascular anomalies are rare, heterogeneous disorders that threaten the health of children. Sirolimus is an important drug therapy, but its high incidence of adverse drug reactions (ADRs) may cause treatment discontinuation and therefore poor disease control. Although prior studies suggest a strong link between sirolimus exposure and ADRs, the quantitative relationship remains unclear. This study aimed to systematically quantify the relationships between steady-state trough sirolimus concentrations (C

methodsWe retrospectively analyzed the data using Bayesian kernel machine regression (BKMR) to characterize associations of C

resultsA total of 257 patients were involved in this study (766-892 blood samples). BKMR results showed the quantitative exposure-response relationships between C

conclusionsThis is the first study to quantify the relationship between C

Indexed as

Immunosuppressive AgentsSirolimusVascular MalformationsAdolescentBayes TheoremChildChild, PreschoolDose-Response Relationship, DrugDrug MonitoringFemaleHumansInfantMaleRetrospective StudiesRisk AssessmentImmunosuppressive AgentsSirolimusAdverse drug reactionsBayesian kernel machine regressionPediatricsSirolimus concentrationsVascular anomalies

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.